Forte Biosciences Inc FBRX

US Biotechnology

$76.60 ▼ -0.49% ($-0.38)

🎢 High Beta 🗓️ Earnings Next Week

Open $76.62

Prev Close $76.98

Day Range $76.54 – $76.74

52W Range $9.10 – $77.20

Market Cap $1.57B

Beta 2.72

EPS (TTM) $-4.58

📋 Company Profile

Industry	Biotechnology
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2017-04-13
Shares Out.	20,490,000
Website	fortebiorx.com/home/default.aspx ↗
Phone	13026587581
Employees	22
Net Income	-$22.1M
Free Cash Flow	-$59.4M
Total Assets	$67.2M
Total Liabilities	$25.1M
Equity	$42.1M

About Forte Biosciences Inc

Forte Biosciences Inc is a clinical-stage biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications. The Company is also advancing clinical development of FB102 in patient-based trials for non-segmental vitiligo and alopecia areata.

Forte Biosciences Inc is a publicly traded company under the ticker symbol FBRX on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.